TY - JOUR
KW - Analgesics, Opioid -- Adverse Effects
KW - Substance Use Disorders -- Drug Therapy
KW - Buprenorphine -- Administration and Dosage
KW - Delayed-Action Preparations
KW - Naloxone -- Administration and Dosage
KW - Administration, Sublingual
KW - Medication Compliance -- Evaluation
KW - Treatment Duration -- Evaluation
KW - Correctional Facilities
KW - Prisoners -- In Adulthood
KW - Human
KW - Pilot Studies
KW - Randomized Controlled Trials
KW - Comparative Studies
KW - Male
KW - Adult
KW - Middle Age
KW - New York
KW - Female
KW - Descriptive Statistics
KW - Treatment Outcomes
KW - Random Assignment
KW - Data Analysis Software
KW - Patient Satisfaction
KW - Funding Source
AU - Joshua D. Lee
AU - Mia Malone
AU - Ryan McDonald
AU - Anna Cheng
AU - Kumar Vasudevan
AU - Babak Tofighi
AU - Ann Garment
AU - Barbara Porter
AU - Keith S. Goldfeld
AU - Michael Matteo
AU - Jasdeep Mangat
AU - Monica Katyal
AU - Jonathan Giftos
AU - Ross MacDonald
A1 - 
AD - Department of Population Health, New York University Grossman School of Medicine, New York; Department of Medicine, New York University Grossman School of Medicine, New York; Correctional Health Services, NYC Health + Hospitals, New York, New York
BT - JAMA Network Open
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 9
CY - Chicago, Illinois
DO - 10.1001/jamanetworkopen.2021.23032
IS - 9
JF - JAMA Network Open
LA - English
M1 - Journal Article
PB - American Medical Association
PP - Chicago, Illinois
PY - 2021
SN - 2574-3805
SP - e2123032
EP - e2123032
EP - 
T1 - Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
T2 - JAMA Network Open
TI - Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1001/jamanetworkopen.2021.23032
VL - 4
VO - 2574-3805
Y1 - 2021
Y2 - 09/08
ER -